Table 2.
Correlation of FDG PET/CT semi-quantitative parameters with metastatic versus non-metastatic NSCLC patients (statistically significant values are highlighted in yellow)
| FDG PET semi- quantitative values | Metastatic Status | p-value | |||||
|---|---|---|---|---|---|---|---|
| Metastatic (thoracic + extra thoracic) | None | ||||||
| Number of patients | Mean Rank | Median | Number of patients | Mean Rank | Median | ||
| Primary T SUVmax | 60 | 51.43 | 12.00 | 65 | 68.43 | 15.55 | 0.007 |
| Primary T MTV | 60 | 63.32 | 36.28 | 65 | 56.73 | 31.69 | 0.298 |
| Primary T TLG | 60 | 60.36 | 252.77 | 65 | 59.65 | 215.25 | 0.911 |
| Lymph node met N SUVmax | 60 | 44.58 | 13.15 | 65 | 32.30 | 8.10 | 0.016 |
| Lymph node met N MTV | 60 | 41.16 | 14.50 | 65 | 38.61 | 11.44 | 0.623 |
| Lymph node met N TLG | 60 | 45.49 | 69.12 | 65 | 33.44 | 32.92 | 0.020 |
| Whole body MTV | 60 | 67.46 | 66.50 | 65 | 53.77 | 43.47 | 0.031 |
| Whole body TLG | 60 | 63.08 | 425.55 | 65 | 58.00 | 309.61 | 0.423 |